Bioorganic and Medicinal Chemistry Letters p. 2467 - 2472 (1998)
Update date:2022-08-05
Topics:
Nerenberg, Jennie B.
Erb, Jill M.
Thompson, Wayne J.
Lee, Hee-Yoon
Guare, James P.
Munson, Peter M.
Bergman, Jeffrey M.
Huff, Joel R.
Broten, Theodore P.
Chang, Raymond S. L.
Chen, Tsing B.
O'Malley, Stacey
Schorn, Terry W.
Scott, Ann L.
Benign prostatic hyperplasia can be managed pharmacologically with α-1 adrenergic receptor antagonists. Agents that demonstrate selectivity for the α-la receptor subtype may offer advantages in clinical applications with respect to hypotensive side effect
View MoreContact:+86-519-86623222
Address:29F/D, 99 Yanling West Road, Changzhou, Jiangsu, China
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
Contact:+86-535-8888888
Address:No.161 Haishi Rd.
Jiangsu Jiuri Chemical Co.,Ltd.
Contact:+86-519-82118868
Address:Tianwang Town, Jurong City, Jiangsu Province, China
Shantou Baokang Pharmaceutical Co., Ltd.
Contact:+86-754-88873487
Address:5/F B Block Huangshan Bldg Huangshan Rd Shantou
Doi:10.1021/jo01271a045
(1968)Doi:10.1039/DT9950001857
(1995)Doi:10.1248/cpb.15.1331
(1967)Doi:10.1039/j39670002700
(1967)Doi:10.1016/S0040-4039(00)72432-4
(1973)Doi:10.1016/0957-4166(95)00201-Y
(1995)
